Next Big COVID-19 Treatment May Be Manufactured Antibodies

Next Big COVID-19 Treatment May Be Manufactured Antibodies
Pipettes and sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the (COVID-19) in San Diego, Calif., on May 22, 2020. Bing Guan/File Photo/Reuters
Reuters
Updated:

As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders—antibodies designed specifically to attack this new virus.

Development of monoclonal antibodies to target the virus has been endorsed by leading scientists. Anthony Fauci, the top U.S. infectious diseases expert, called them “almost a sure bet” against COVID-19.